Dr. Fadi Haddad is an Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston. With a prolific record of over 80 peer-reviewed publications spanning hematology and oncology, Dr. Haddad has made substantial contributions to the field. He has presented his research at prominent national and international conferences, including ASH, ASCO, and EHA, earning widespread recognition. His dedication to hematology has been acknowledged through multiple awards that highlight his impact and expertise. As the leader of the chronic myeloid leukemia program at MD Anderson, Dr. Haddad spearheads innovative research and treatment protocols for patients with leukemia. He has played a pivotal role in designing and conducting numerous phase II clinical trials, focusing primarily on chronic myeloid leukemia and acute lymphoblastic leukemia. His work not only shapes the future of leukemia treatment but also demonstrates his commitment to advancing patient care and therapeutic possibilities in oncology.